Product Code: BIO233A
Highlights:
The global in vitro diagnostic (IVD) quality controls market should reach $1.6 billion by 2027 from $1.2 billion in 2022 at a compound annual growth rate (CAGR) of 5.5% for the forecast period of 2022 to 2027.
The immunodiagnostics segment of the global IVD quality controls market is expected to grow from $365.1 million in 2022 to $457.4 million in 2027 at a CAGR of 4.6% for the forecast period of 2022 to 2027.
The molecular diagnostics segment of the global IVD quality controls market is expected to grow from $217.5 million in 2022 to $305.6 million in 2027 at a CAGR of 7.0% for the forecast period of 2022 to 2027.
Report Scope:
The current report provides detailed information regarding the in vitro diagnostics quality controls market. This report highlights the current and future market potential of in vitro diagnostics controls and a detailed analysis of the drivers and challenges in the market. The report also covers market projections to 2027 and market rank for key market players. It also covers the competitive environment and regulatory scenario. The report details the market share of IVD controls based on test type, products and services, manufacturer, application and end user.
Based on test type, the market is segmented into immunoassays, clinical chemistry, hematology and hemostasis, molecular diagnostics, microbiology and others. Based on products and services, controls are categorized into quality control products, data management solutions, and quality assurance services. Based on manufacturer, the market is segmented into third-party controls and OEM controls. Based on end users, the market is segmented into hospitals, diagnostic laboratories and academic institutions.
The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. The report also includes impact of the COVID-19 pandemic on this market.
By geography, the market has been segregated into North America, Europe, Asia-Pacific and the Rest of the world. The North America region includes the U.S., Canada and Mexico. Europe includes Germany, U.K., Italy and Rest of Europe. Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific.
For market estimates, data has been provided for the 2020 as the historic year, 2021 as the base year and forecast for 2027.
Report Includes:
- 26 data tables and 24 additional tables
- An overview of the global market for in vitro diagnostics (IVD) quality controls market
- Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022 with projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for in vitro diagnostics (IVD) quality controls market, based on test type, manufacturer, products and services, end user, and region
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
- Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Abbott Laboratories, Bio-Rad Laboratories Inc., LGC Ltd., Siemens Healthineers AG, and ThermoFisher Scientific Inc.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of This Report
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Summary and Highlights
- Highlights of the Market for IVD Quality Controls
Chapter 3 Market Background and Technology
- Overview
- Characteristics of Quality Control Materials
Chapter 4 Market Dynamics
- Market Drivers
- Growing Demand for Third-Party Controls
- Increasing Focus on Internal Quality Control in Point-of-Care Tests
- Rising Aging Population and Global Incidence of Chronic Diseases
- Market Challenges
- Matrix Effects with QC Materials
- Lack of Well-Defined Standards for Molecular QC Tests
- Packaging Challenges
- Stringent Regulatory Framework
Chapter 5 Market Breakdown by Test Type
- Global Market for In Vitro Diagnostic (IVD) Quality Controls
- Market Analysis
- Immunodiagnostic Quality Controls
- Clinical Chemistry Quality Controls
- Molecular Diagnostic Quality Controls
- Market Size and Forecast
- Hematology and Hemostasis Quality Controls
- Market Size and Forecast
- Microbiology Quality Controls
- Market Size and Forecast
- Other Quality Controls
- Market Size and Forecast
Chapter 6 Market Breakdown by Type of Manufacturer
- Global Market for IVD Quality Controls by Type of Manufacturer
- Third-Party Controls
- OEM Controls
Chapter 7 Market Breakdown by Product and Service
- Global Market for IVD Quality Controls by Product and Service
- IVD Quality Control Products
- Global Market for IVD Quality Control Products Based on Product Type
- Serum/Plasma-Based Quality Controls
- Whole Blood-Based Quality Controls
- Urine Based Quality Controls
- Other Quality Controls
- Data Management Services
- Quality Assurance Services
Chapter 8 Market Breakdown by End User
- Global Market for IVD Quality Controls by End User
- Diagnostic Laboratories
- Hospitals and Clinics
- Point-of-Care Centers
- Research Institutions
- Others
Chapter 9 Market Breakdown by Region
- Global Market for IVD Quality Controls by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Rest of Europe
- Asia-Pacific
- China
- Australia
- Japan
- Rest of Asia-Pacific
- Rest of the World
Chapter 10 Regulatory Scenario
- IVD Regulations in North America
- United States
- Canada
- Mexico
- IVD Regulations in Europe
- IVD Regulations in Asia-Pacific
- Japan
- China
- India
- Australia and New Zealand
- Malaysia
- Singapore
- IVD Regulations in RoW (Latin America, Africa and Middle East)
- Brazil
- Israel
- Saudi Arabia
- South Africa
Chapter 11 Impact of the COVID-19 Pandemic
- Impact of COVID-19 on the IVD Quality Controls Market
- Increased Demand for Molecular and Immunoassay Assay Quality Controls
- Decreased Demand for Routine Diagnostic Testing
- Delays in the Implementation of Regulations
- Shortage of Raw Materials
Chapter 12 Competitive Landscape
- Overview
- Recent Developments of Key Market Players
- Growth Strategies
Chapter 13 Company Profiles
- ABBOTT LABORATORIES
- BECTON, DICKINSON & CO.
- BIOMERIEUX SA
- BIO-RAD LABORATORIES INC.
- BIO-TECHNE CORP.
- DANAHER
- EKF DIAGNOSTICS HOLDINGS PLC
- LGC LTD.
- MICROBIOLOGICS INC.
- MINDRAY MEDICAL INTERNATIONAL LTD.
- QNOSTICS LTD.
- QUIDEL CORP.
- RANDOX LABORATORIES LTD.
- ROCHE DIAGNOSTICS CORP.
- SERO AS
- SIEMENS HEALTHINEERS AG
- SYSMEX
- THERMOFISHER SCIENTIFIC INC.
- ZEPTOMETRIX LLC